| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2006;81:770-781
© 2006 The Society of Thoracic Surgeons
a Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa Hospital, Ottawa
b Division of Clinical Hematology, Ottawa Hospital, Ottawa
c Department of Medicine, McMaster University, Hamilton, Ontario, Canada
* Address correspondence to Dr Lam, University of Ottawa Heart Institute, 40 Ruskin Street, Suite H3404, Ottawa, Ontario, Canada K1Y 4W7 (Email: bklam{at}ottawaheart.ca).
The optimal approach to early postoperative anticoagulation after mechanical valve implantation remains controversial. This review article examines the pathogenesis of thrombus formation and the different strategies for early postoperative anticoagulation. The most commonly reported anticoagulation regimens had the after estimates of early postoperative thromboembolism and hemorrhage: oral anticoagulation alone (0.9%, 3.3%); oral anticoagulation with intravenous unfractionated heparin (1.1%, 7.2%); and oral anticoagulation with low molecular weight heparin (0.6%, 4.8%). Although intravenous heparin may be associated with a higher incidence of hemorrhage, a randomized trial is needed to provide the best evidence regarding early postoperative anticoagulation after mechanical valve implantation. Nearly four decades have passed since the first mechanical prosthetic valves were implanted. Frequent thromboembolic complications with the first mechanical valves led to recommendations of universal anticoagulation for these patients. Since then, several design changes and modifications have been made to improve the longevity, hemodynamics, and thrombogenicity of newer generation mechanical valves. With improved blood flow, less stasis, and less thrombogenic materials, lower rates of thromboembolism have been reported [1]. Despite these advances however, thromboembolism and anticoagulant-related bleeding continue to account for 75% of all complications after mechanical valve replacement [2]. Occurring most commonly within six months after implantation [2], these complications can adversely affect mortality and quality of life. Furthermore, the threat of their occurrence creates a psychological burden for each patient with a mechanical valve. The need for life-long anticoagulation in patients with mechanical valves is not in dispute, and the perioperative management of anticoagulation during non-cardiac surgery has been reviewed extensively [3]. However, the approach to early postoperative anticoagulation after mechanical valve implantation is still a matter of debate. The optimal intensity and timing of anticoagulation to prevent early thromboembolism after valve replacement surgery without postoperative bleeding complications is unknown. Hence, many anticoagulation protocols have been proposed, but a lack of consensus remains. The objectives of this study were (1) to reexamine the pathogenesis of thrombus formation and the need for anticoagulation; (2) to critically review the literature on early postoperative anticoagulation strategies; and (3) provide an estimate of the incidence of bleeding and thromboembolism for each approach to early postoperative anticoagulation.
This article has been cited by other articles:
|
|
 |
|
  N Allou, P Piednoir, C Berroeta, S Provenchere, H Ibrahim, G Baron, P Montravers, B Iung, I Philip, and N Ajzenberg Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin Heart, October 15, 2009; 95(20): 1694 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Charokopos, P. Antonitsis, P. Artemiou, E. Rouska, C. Foroulis, and C. Papakonstantinou Acute mechanical prosthetic valve thrombosis after initiating oral anticoagulation therapy. Is bridging anticoagulation with heparin required? Interactive CardioVascular and Thoracic Surgery, October 1, 2009; 9(4): 685 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Edwin, M. M. Tettey, E. Aniteye, L. Sereboe, M. Tamatey, K. Entsua-Mensah, D. Kotei, and K. Frimpong-Boateng Freedom from thromboembolism despite prolonged inadequate anticoagulation BMJ Case Reports, September 15, 2009; 2009(sep15_1): bcr0720092066 - bcr0720092066. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Colli, J.-P. Verhoye, R. Heijmen, J. T. Strauch, J. A.J. Hyde, D. Pagano, M. Antunes, H. Koertke, S. K. Ohri, D. H. L. Bail, et al. Corrigendum to "Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results" [Eur. J. Cardiothorac. Surg. 33 (2008) 531-536] Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 429 - 429. [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Spyropoulos Outpatient-Based Primary and Secondary Thromboprophylaxis With Low-Molecular-Weight Heparin Clinical and Applied Thrombosis/Hemostasis, January 1, 2008; 14(1): 63 - 74. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Talwar, A. Mathur, S. K. Choudhary, R. Singh, and A. S. Kumar Aortic Valve Replacement With Mitral Valve Repair Compared With Combined Aortic and Mitral Valve Replacement Ann. Thorac. Surg., October 1, 2007; 84(4): 1219 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. U. Jones, J. B. Muhlestein, K. W. Jones, D. G. Renlund, T. L. Bair, T. J. Bunch, B. D. Horne, D. L. Lappe, J. L. Anderson, and D. B. Doty Reply. Ann. Thorac. Surg., October 1, 2006; 82(4): 1574 - 1575. [Full Text] [PDF]
|
|
|
|
|
|
V. Close, M. Purohit, M. Tanos, and S. Hunter Should patients post-cardiac surgery be given low molecular weight heparin for deep vein thrombosis prophylaxis? Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 624 - 629. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
